Global DNA methylation is not elevated in blood samples from Machado-Joseph disease mutation carriers

References

• Greenberg MVC, Bourc’his D. The diverse roles of DNA methylation in mammalian development and disease. Nat Rev Mol Cell Biol. 2019;20(10):590–7. doi: 10.1038/s41580-019-0159-6
   PubMed Web of Science ®Google Scholar
• Bettencourt C, Foti SC, Miki Y, et al. White matter DNA methylation profiling reveals deregulation of HIP1, LMAN2, MOBP, and other loci in multiple system atrophy. Acta Neuropathol. 2020;139(1):135–156. doi: 10.1007/s00401-019-02074-0
   PubMed Web of Science ®Google Scholar
• Murthy M, Cheng YY, Holton JL, et al. Neurodegenerative movement disorders: an epigenetics perspective and promise for the future. Neuropathol Appl Neurobiol. 2021;47(7):897–909. doi: 10.1111/nan.12757
   PubMed Web of Science ®Google Scholar
• Sanchez-Mut JV, Heyn H, Vidal E, et al. Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns. Transl Psychiatry. 2016;6(1):e718. doi: 10.1038/tp.2015.214
   PubMedGoogle Scholar
• Gutierrez A, Corey-Bloom J, Thomas EA, et al. Evaluation of biochemical and epigenetic measures of peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in Huntington’s disease patients. Front Mol Neurosci. 2019;12:335. doi: 10.3389/fnmol.2019.00335
   PubMed Web of Science ®Google Scholar
• Singh AK, Halder-Sinha S, Clement JP, et al. Epigenetic modulation by small molecule compounds for neurodegenerative disorders. Pharmacol Res. 2018;132:135–148. doi: 10.1016/j.phrs.2018.04.014
   PubMed Web of Science ®Google Scholar
• Kondo N, Tohnai G, Sahashi K, et al. DNA methylation inhibitor attenuates polyglutamine-induced neurodegeneration by regulating Hes5. EMBO Mol Med. 2019;11(5). doi: 10.15252/emmm.201708547
   PubMed Web of Science ®Google Scholar
• Lokk K, Modhukur V, Rajashekar B, et al. DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns. Genome Biol. 2014 Apr;15(4):r54.
   PubMed Web of Science ®Google Scholar
• Lu AT, Narayan P, Grant MJ, et al. DNA methylation study of Huntington’s disease and motor progression in patients and in animal models. Nat Commun. 2020Sep;11(1):4529.
   PubMed Web of Science ®Google Scholar
• Hamzeiy H, Savaş D, Tunca C, et al. Elevated global DNA methylation is not exclusive to amyotrophic lateral sclerosis and is also observed in spinocerebellar ataxia types 1 and 2. Neurodegener Dis. 2018;18(1):38–48. doi: 10.1159/000486201
   PubMed Web of Science ®Google Scholar
• Ding D, Wang C, Chen Z, et al. Polymorphisms in DNA methylation–related genes are linked to the phenotype of Machado-Joseph disease. Neurobiol Aging. 2019;75:.e225.1–.e225.8. doi: 10.1016/j.neurobiolaging.2018.11.002
   Web of Science ®Google Scholar
• Emmel VE, Alonso I, Jardim LB, et al. Does DNA methylation in the promoter region of the ATXN3 gene modify age at onset in MJD (SCA3) patients? Clinical Genetics. 2011;79(1):100–102. doi: 10.1111/j.1399-0004.2010.01508.x
   PubMed Web of Science ®Google Scholar
• Li J, Shu A, Sun Y, et al. DNA methylation age acceleration is associated with age of onset in Chinese spinocerebellar ataxia type 3 patients. Neurobiol Aging. 2022;113:1–6. doi: 10.1016/j.neurobiolaging.2022.02.002
   PubMed Web of Science ®Google Scholar
• Wang C, Peng H, Li J, et al. Alteration of methylation status in the ATXN3 gene promoter region is linked to the SCA3/MJD. Neurobiol Aging. 2017;53:.e192.5–.e192.10. doi: 10.1016/j.neurobiolaging.2016.12.014
   Web of Science ®Google Scholar
• Zhao H, Yang L, Dong Y, et al. Phenotypic variance in monozygotic twins with SCA3. Molec Gen & Gen Med. 2020;8(10):e1438. doi: 10.1002/mgg3.1438
   PubMed Web of Science ®Google Scholar
• McLoughlin HS, Moore LR, Paulson HL. Pathogenesis of SCA3 and implications for other polyglutamine diseases. Neurobiol Dis. 2020;134:104635. doi: 10.1016/j.nbd.2019.104635
   PubMed Web of Science ®Google Scholar
• Kawaguchi Y, Okamoto T, Taniwaki M, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet. 1994;8(3):221–228. doi: 10.1038/ng1194-221
   PubMed Web of Science ®Google Scholar
• Costa MDC, Paulson HL. Toward understanding Machado-Joseph disease. Prog Neurobiol. 2012;97(2):239–257. doi: 10.1016/j.pneurobio.2011.11.006
   PubMed Web of Science ®Google Scholar
• Ferreira AF, Raposo M, Shaw ED, et al. Tissue-specific vulnerability to apoptosis in Machado-Joseph disease. Cells. 2023;12(10):1404. doi: 10.3390/cells12101404
   PubMed Web of Science ®Google Scholar
• Kazachkova N, Raposo M, Ramos A, et al. Promoter Variant alters expression of the autophagic BECN1 gene: implications for clinical manifestations of Machado-Joseph disease. Cerebellum. 2017;16(5–6):957–963. doi: 10.1007/s12311-017-0875-4
   PubMed Web of Science ®Google Scholar
• Raposo M, Bettencourt C, Maciel P, et al. Novel candidate blood-based transcriptional biomarkers of Machado-Joseph disease. Mov Disord. 2015;30(7):968–975. doi: 10.1002/mds.26238
   PubMed Web of Science ®Google Scholar
• Raposo M, Bettencourt C, Ramos A, et al. Promoter variation and expression levels of inflammatory genes IL1A, IL1B, IL6 and TNF in blood of spinocerebellar ataxia type 3 (SCA3) patients. Neuromolecular Med. 2017;19(1):41–45. doi: 10.1007/s12017-016-8416-8
   PubMed Web of Science ®Google Scholar
• Raposo M, Hübener-Schmid J, Ferreira AF, et al. Blood transcriptome sequencing identifies biomarkers able to track disease stages in spinocerebellar ataxia type 3. Brain. 2023;146(10):4132–4143. doi: 10.1093/brain/awad128
   PubMed Web of Science ®Google Scholar
• Lima M, Raposo M, Ferreira A, et al. The homogeneous Azorean Machado-Joseph disease cohort: characterization and contributions to advances in research. Biomedicines. 2023;11(2):247. doi: 10.3390/biomedicines11020247
   PubMed Web of Science ®Google Scholar
• Raposo M, Bettencourt C, Melo ARV, et al. Novel Machado-Joseph disease-modifying genes and pathways identified by whole-exome sequencing. Neurobiol Dis. 2022;162:105578. doi: 10.1016/j.nbd.2021.105578
   PubMed Web of Science ®Google Scholar
• Maas RPPWM, van Gaalen J, Klockgether T, et al. The preclinical stage of spinocerebellar ataxias. Neurology. 2015;85(1):96–103. doi: 10.1212/WNL.0000000000001711
   PubMed Web of Science ®Google Scholar
• Bettencourt C, Fialho RN, Santos C, et al. Segregation distortion of wild-type alleles at the Machado-Joseph disease locus: a study in normal families from the Azores islands (Portugal). J Hum Genet. 2008;53(4):333–339. doi: 10.1007/s10038-008-0261-7
   PubMed Web of Science ®Google Scholar
• Garcia TP, Marder K. Statistical approaches to longitudinal data analysis in neurodegenerative diseases: Huntington’s disease as a model. Curr Neurol Neurosci Rep. 2017;17(2):14. doi: 10.1007/s11910-017-0723-4
   PubMed Web of Science ®Google Scholar
• Kurdyukov S, Bullock M. DNA methylation analysis: choosing the right method. Biology (Basel). 2016;5(1):3. doi: 10.3390/biology5010003
   PubMedGoogle Scholar
• Celik Uzuner S. Mitochondrial DNA methylation misleads global DNA methylation detected by antibody-based methods. Anal Biochem. 2020;601:113789. doi: 10.1016/j.ab.2020.113789
   PubMed Web of Science ®Google Scholar
• Picard M. Blood mitochondrial DNA copy number: what are we counting? Mitochondrion. 2021 Sep;60:1–11.
   PubMed Web of Science ®Google Scholar
• Li S, Tollefsbol TO. DNA methylation methods: global DNA methylation and methylomic analyses. Methods. 2021;187:28–43. doi: 10.1016/j.ymeth.2020.10.002
   PubMed Web of Science ®Google Scholar
• Fuke C, Shimabukuro M, Petronis A, et al. Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann Hum Genet. 2004;68(3):196–204. doi: 10.1046/j.1529-8817.2004.00081.x
   PubMedGoogle Scholar